歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗CAV3多克隆抗體

產(chǎn)品中心

  • 兔抗CAV3多克隆抗體

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW4375
    • 應(yīng)用 : 僅用于科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:35
  • 商品詳情
  • 參考文獻
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱:兔抗CAV3多克隆抗體   

英文名稱:
Anti-CAV3 rabbit polyclonal antibody

別      名:
LQT9; VIP21; LGMD1C; VIP-21

相關(guān)類別: 一抗

儲      存:
冷凍(-20℃)

宿      主: Rabbit

抗      原: CAV3

反應(yīng)種屬: Human

標(biāo) 記 物: Unconjugate

克隆類型: rabbit polyclonal

技術(shù)規(guī)格

Background:

This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.

Applications:

ELISA, WB, IHC

Name of antibody:

CAV3

Immunogen:

Synthetic peptide of human CAV3

Full name:

caveolin 3

Synonyms:

LQT9; VIP21; LGMD1C; VIP-21

SwissProt:

P56539

IHC positive control:

Human gastric cancer and human thyroid cancer

IHC Recommend dilution:

50-200

WB Predicted band size:

17 kDa

WB Positive control:

Human fetal muscle tissue

WB Recommended dilution:

500-2000